|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Incidence and Character-istics of Bacteremia among Children in Rural Ghana显示文摘 | MAJA VERENA NIELSEN NIMAKO SARPONG RALF KRUMKAMP | 2012 | Plos One2012，7，： | 1 |
| 2 | Human papillovirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade Ⅲ显示文摘 | Nimako M Fiander AN Wilkinson GW | 1997 | Cancer Res1997，57，： | 1 |
| 3 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6and E7 proteins as immunotherapy for cervical Cancer显示文摘 | Borysiewicz LK Fiander A Nimako M | | 0，，9014： | 1 |
| 4 | Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade Ⅲ 显示文摘 | Nimako M Fiander AN Wilkinson GW | 1997 | Cancer Res1997，57，21： | 1 |
| 5 | A recombinant vaccinia virus encoding human papillomavirus type 16 and 18,E6 and E7 proteins as immmunotherapy for cervical cancer显示文摘 | LK Borysiewicz A Fiander M Nimako | 1996 | LANET1996，347，11： | 1 |
| 6 | Urine output on an intensive care unit:casecontrol study显示文摘 | Solomon AW Kirwan C J Alexander ND Nimako K Jurukov A Forth R J | | 0，，： | 1 |
| 7 | A recombinant vaceinia virus encoding human papillomavirus type 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 8 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Gene Ther1996，347，9014： | 1 |
| 9 | A recombinant vaceinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 10 | Under usage of zole- dronic acid in non-small cell lung cancer patients with metastatic bone disease-- a short communication显示文摘 | Calderone R Nimako K Leary A | 2011 | Eur J Cancer2011，47，11： | 1 |
| 11 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 12 | A recombinant vaccinia virus encoding human papillomavirus type 16 and 18,E6 and E7 protein as immunotherapy for cervical cancer显示文摘 | Broysiewicz L K Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 13 | A recombinant vaccinia Virus encoding human types 16 and18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | Fiander A Nimako M | 1996 | Lancet1996，347，9014： | 1 |
| 14 | Multimorbidity of chronic diseases among adult patients presenting to an inner-city clinic inGhana 显示文摘 | Nimako BA Baiden F Sackey SO | 2013 | Global Health2013，9，： | 1 |
| 15 | Seasonal variability and meteorological factors: retrospective study of the incidence of pulmonary embolism from a large United kingdom teaching hospital显示文摘 | Nimako K Poloniecki J Draper A | 2012 | Respir Care2012，57，8： | 1 |
| 16 | A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer 显示文摘 | Borysiewicz LK Fiander A Nimako M | 1996 | Gene Ther1996，347，： | 1 |
| 17 | A re- combinant vaccinia virus encoding human papillomavirus type 16 and 18,E6 and E7 proteins as immunotherapy for cervical cancer显示文摘 | BORYSIEWICZ LK FIANDER A NIMAKO M | 1996 | Lancet1996，347，9014： | 1 |
| 18 | Motivation for Customer Complaining and Non-Complaining Behaviour Towards Mobile Telecommu- nication Services显示文摘 | Nimako S G Mcnsah A F | 2012 | Asian Journal of Business Management2012，，3： | 1 |
| 19 | A retrospective review to evaluate the safety of right heart catheterization via the internal jugular vein in the assessment of pulmonary hypertension显示文摘 | Ranu H Smith K Nimako K | 2010 | Clin Cardiol2010，33，5： | 1 |
| 20 | Under usage of zoledronic acid in small cell lung cancer patients with metastatic bone disease-a short communication显示文摘 | R Calderone K Nimako A Leary S Popat M E R O'Brien | 2011 | European journal of cancer2011，47，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员